Physician

Brenda M Vozza, MD

According to 2025 Medicare claims, Brenda Vozza, MD (NPI: 1588616676) practices internal medicine in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is BROOKRIDGE INTERNAL MEDICINE ASSOCIATES, PA (NPI: 1396796553) and primary practice location at 75601-6505. Vozza is affiliated with the Aledade 158 TX MSSP Enhanced (ACO ID: A5361), participating under the MSSP model.

Vozza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 10,280 HCPCS/CPT codes, and received $346,629 in Medicare payments. The top billing code was 80061 (Blood test, lipids (cholesterol and triglycerides)). Part D data shows 23,673 prescription claims across 966 beneficiaries totaling $2,967,932 in drug costs, led by Jardiance (Empagliflozin). DME data shows 245 claims. Open Payments data shows 101 records totaling $1,934. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,921,671 to $2,967,932. In contrast, DME billing represents a smaller volume and declined steadily, from $87,255 to $33,330.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	838	14,883	$461,833
2016	802	14,671	$430,769
2017	777	16,831	$511,344
2018	805	16,416	$478,612
2019	646	10,422	$316,263
2020	694	10,563	$360,245
2021	659	12,062	$394,176
2022	599	12,602	$463,761
2023	602	12,478	$465,181
2024	516	10,280	$346,629

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	970	28,470	$1,921,671
2016	943	27,818	$1,918,622
2017	931	25,813	$1,933,591
2018	977	22,696	$1,717,555
2019	981	21,302	$1,753,113
2020	1,083	27,047	$2,131,333
2021	1,099	29,881	$2,402,593
2022	1,023	23,703	$2,395,847
2023	979	22,681	$2,666,426
2024	966	23,673	$2,967,932

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	743	2,251	$117,263
2016	610	1,913	$78,474
2017	389	1,227	$35,124
2018	301	1,007	$22,479
2019	180	988	$23,237
2020	135	818	$32,475
2021	85	685	$33,799
2022	67	577	$37,698
2023	43	525	$37,020
2024	27	245	$16,077

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80061	Blood test, lipids (cholesterol and triglycerides)	273	612	$13
36415	Insertion of needle into vein for collection of blood sample	297	877	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	296	801	$8
80076	Liver function blood test panel	265	622	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	291	726	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	398	16,806	$336,391
Mounjaro	Tirzepatide	188	6,302	$239,629
Farxiga	Dapagliflozin Propanediol	224	10,339	$184,023
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	239	8,170	$174,894
Eliquis	Apixaban	250	8,644	$173,059

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	21	$10,692
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$2,138
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	18	$788
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	35	$616
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	21	$517

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$1,934	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brenda M. Vozza, MD?

Tedicare shows public-source Medicare data for Brenda M. Vozza, MD (NPI 1588616676), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brenda M. Vozza, MD have ACO affiliation data?

Brenda M. Vozza, MD is shown with ACO affiliation data for Aledade 158 TX MSSP Enhanced (MSSP, ACO ID A5361).

What billing organization is linked to Brenda M. Vozza, MD?

Brenda M. Vozza, MD is linked to BROOKRIDGE INTERNAL MEDICINE ASSOCIATES, PA (billing NPI 1396796553) in the available physician profile data.

Does Brenda M. Vozza, MD have Open Payments data?

Brenda M. Vozza, MD has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.